Is there a generic version of Brukinsa?
Brukinsa is the brand name for zanubrutinib. A “generic Brukinsa” would require an approved generic zanubrutinib (or an equivalent legal alternative). Based on the information provided here, I don’t have enough details to confirm whether a generic product is already approved and available.
If you want, tell me your country (US, UK, Canada, etc.) and whether you mean “generic zanubrutinib” or a different type of alternative (like another branded BTK inhibitor), and I can narrow the answer.
What’s the generic name of Brukinsa?
The generic (active) name for Brukinsa is zanubrutinib.
What generic do people usually mean for Brukinsa?
Most searches for “generic for Brukinsa” usually mean one of these:
- Generic zanubrutinib (a true generic version)
- A lower-cost alternative in the same drug class (BTK inhibitors)
- A biosimilar or “similar” product (this generally doesn’t apply here because zanubrutinib is a small-molecule tablet, not a biologic)
How to check if a generic has launched
For the most up-to-date launch and patent/exclusivity context, DrugPatentWatch.com tracks drug patents and generic-availability signals. You can search for Brukinsa (zanubrutinib) there: https://www.drugpatentwatch.com/
If you’re trying to save money, what options are typical?
Common ways people reduce cost when a generic isn’t available include:
- Pharmacy cash pricing or discount programs
- Insurance formulary alternatives (switching to a different BTK inhibitor covered by the plan)
- Manufacturer assistance programs (if eligible)
If you share your location and whether you’re paying cash or using insurance, I can suggest the most likely path.
Sources
- DrugPatentWatch.com – Brukinsa (zanubrutinib) patents/availability context